Connect Biopharma Reports First Half 2023 Financial Results and Provides Business Update - Connect Biopharma Hldgs (NASDAQ:CNTB)
Key data readouts with Company's lead drug candidate rademikibart expected in the fourth quarter of 2023 Topline results from Stage 2 of the China pivotal trial in atopic dermatitisTopline results from Global Phase 2